• Jump to navigation (n)
  • Jump to content
  • Sitemap
Novalgen Novalgen
  • About us
    • Back
    • Overview
    • Our strategy
    • Our board
    • Our executive team
    • Our history
    • Our investors
    • Our values
  • Innovation
    • Back
    • Overview
    • Our science
    • Platform and application
  • Patients & Families
    • Back
    • Overview
    • Treatments
    • Patient organisations
    • Clinical trials
    • About disease areas
  • Pipeline
  • News
  • Careers
    • Back
    • Overview
    • Vacancies
  • Contact

News

Explore

NovalGen announces data presentation at the Upcoming XIX International Workshop on Chronic Lymphocytic Leukemia

17.09.2021

NovalGen doses first patient in Phase I study in Chronic Lymphocytic Leukemia & Mantle Cell Lymphoma

09.06.2021

NovalGen presents data at American Society of Clinical Oncology for novel ROR1xCD3 bispecific antibody for non-Hodgkin lymphoma

20.05.2021

NovalGen receives CTA approval to start a Phase 1/2 first in human study to evaluate the safety, pharmacokinetics and efficacy of NVG-111 in Chronic Lymphocytic Leukemia & Mantle Cell Lymphoma

07.04.2021

NovalGen enters strategic partnership with HALIX B.V. to manufacture clinical trial materials

22.02.2021

NovalGen announces updates to its executive management team

19.02.2021

Novalgen licenses mAbsolve’s QumAb™ technology to improve the safety of therapeutic antibodies

06.10.2020

Media Coverage

Published in the March 2021 edition of MedNous, a publication of Evernow Publishing Ltd.

Read more
Novalgen
  • About us
  • Innovation
  • Patients & Families
  • Pipeline
  • News
  • Careers
  • © Novalgen 2022
  • Privacy and cookies
  • Accessibility
  • Contact
  • LinkedIn
  • Home
  • About us
    • Back
    • About us
    • About us overview
    • Our strategy
    • Our board
    • Our executive team
    • Our history
    • Our investors
    • Our values
  • Innovation
    • Back
    • Innovation
    • Innovation overview
    • Our science
    • Platform and application
  • Patients & Families
    • Back
    • Patients & Families
    • Patients & Families overview
    • Treatments
    • Patient organisations
    • Clinical trials
    • About disease areas
  • Pipeline
  • News
  • Careers
    • Back
    • Careers
    • Careers overview
    • Vacancies
  • Contact